154 related articles for article (PubMed ID: 6896823)
1. Effects of prolonged treatment of pirenzepine 2HCl on gastric secretion and plasma gastrin levels in rats.
Okabe S; Tabata K; Kawakami M
Arzneimittelforschung; 1982; 32(6):664-8. PubMed ID: 6896823
[TBL] [Abstract][Full Text] [Related]
2. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
[TBL] [Abstract][Full Text] [Related]
3. Actions of pirenzepine-dihydrochloride (LS-519 Cl) on gastric juice secretion, gastric motility and experimental gastric ulcer.
Matsuo Y; Seki A
Arzneimittelforschung; 1979; 29(7):1028-35. PubMed ID: 582994
[No Abstract] [Full Text] [Related]
4. Inhibition of pentagastrin and insulin-stimulated gastric secretion by pirenzepine in healthy and duodenal ulcer subjects.
Bianchi Porro G; Prada A; Petrillo M; Grossi M
Scand J Gastroenterol Suppl; 1979; 57():63-7. PubMed ID: 396660
[TBL] [Abstract][Full Text] [Related]
5. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
[TBL] [Abstract][Full Text] [Related]
6. The effect of pirenzepine on gastric acid secretion and gastrin release induced by bombesin and meal in the dog.
Del Tacca M; Soldani G; Polloni A; Bernardini C; Martinotti E
Scand J Gastroenterol Suppl; 1982; 72():105-10. PubMed ID: 6957977
[TBL] [Abstract][Full Text] [Related]
7. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
Konturek SJ; Obtulowicz W; Kwiecień N; Dobrzańska M; Swierczek J; Kopp B; Olesky J
Scand J Gastroenterol Suppl; 1980; 66():63-9. PubMed ID: 6941379
[TBL] [Abstract][Full Text] [Related]
8. Gastric cytoprotection by pirenzepine is not mediated by catecholamines.
Martinotti E; Bernardini C; Del Tacca M; Pellegrini M; Soldani G; Bertelli A
Acta Physiol Hung; 1984; 64(3-4):219-24. PubMed ID: 6549422
[TBL] [Abstract][Full Text] [Related]
9. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Londong W; Londong V; Prechtl R; Weber T; von Werder K
Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
[TBL] [Abstract][Full Text] [Related]
10. The effects of prolonged administration of cimetidine or pirenzepine on gastric mucosal cell kinetics, serum gastrin levels and acid secretory responses in rats.
Del Tacca M; Gherardi G; Polloni A; Bernardini C; Petrucci A
Int J Tissue React; 1987; 9(5):419-26. PubMed ID: 3667111
[TBL] [Abstract][Full Text] [Related]
11. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
12. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
14. The effect of pirenzepine on meal-stimulated gastric acid secretion, gastrin release and gastric emptying.
Bianchi Porro G; Prada A; Parente F; Sangaletti O; Lazzaroni M
Scand J Gastroenterol Suppl; 1982; 72():159-62. PubMed ID: 6957983
[TBL] [Abstract][Full Text] [Related]
15. The influence of various secretory inhibitors on peptic activity.
Gabryelewicz A; Laszewicz W; Sarosiek J
Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gastrin secretion by pirenzepine (LS 519) in treatment of gastric ulcer.
Tatsuta M; Itoh T; Okuda S; Tamura H; Baba M; Yamamura H
Scand J Gastroenterol; 1981; 16(2):269-71. PubMed ID: 6895560
[TBL] [Abstract][Full Text] [Related]
17. The effect of different doses of pirenzepine on gastric secretion stimulated by modified shamfeeding in man.
Stockbrügger RW; Jaup BH; Dotevall G
Scand J Gastroenterol Suppl; 1982; 72():111-7. PubMed ID: 6957978
[TBL] [Abstract][Full Text] [Related]
18. Effect of pirenzepine on meal-stimulated acid secretion and gastrin release in normal man.
Mignon M; Vatier J; Bauer P; Bonfils S
Scand J Gastroenterol Suppl; 1982; 72():145-51. PubMed ID: 6753112
[TBL] [Abstract][Full Text] [Related]
19. Antiulcerogenic effect of a pyrido-benzodiazepine derivative (L-S 519) on experimental ulcers.
Kitagawa H; Kurahashi K; Fujiwara M; Kohei H
Arzneimittelforschung; 1978; 28(11):2122-7. PubMed ID: 582916
[TBL] [Abstract][Full Text] [Related]
20. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
